Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CREOGS > CREOG > Flashcards

CREOG Flashcards

1
Q

Teratogen: Valproic Acid

A

folate antagonist–> spina bifida (NTDs), craniofacial defects (cleft palate), heart defects (ASD); okay to take when breastfeeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Teratogen: Warfarin

A

nasal hypoplasia, chondrodysplasia (Shortened limbs), micro-ophthalmia, IUGR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Teratogen: Methimazole

A

cutis aplasia (congenital skin defect), esophageal or choanal atresia

(Therefore avoid in first trimester!, PTU Phirst and Meth next!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Luteoma

A

ovarian tumors during pregnancy, typically bilateral, some can secrete androgens, manage expectantly, if large >5cm surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Granulosa cell tumor

A

Typically present as large unilateral mass, produce estrogen–> AUB, PMB, precocious puberty; DO EMB, Markers: inhibin/AMH, Call Exner bodies (coffee-bean nuclei

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sertoli-Leydig

A

Often produce androgens and associated with virilizing symptoms: hirsuitism, amenorrhea, abdominal pain (mean size 16cm at presentation), AFP may be elevated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dysgerminoma

A

Mostly in adolescents and women in 20s, elevated LDH, fried-egg cells, solid and can present bilaterally, commonly present with abdominal pain, fever, vaginal bleeding and even ascites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Yolk sac tumor

A

Elevated AFP, present with LARGE adnexal mass, aggressive tumors often with hemorrhage or necrosis and rapid growth; Schiller-Duval bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Fibromas

A

Most common type of sex cord stromal tumor, benign, unilateral, generally in postmenopausal women; think Meig’s syndrome: fibromas + ascites + pleural effusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mullerian Agenesis (MRKH syndrome)

A

Normal ovaries, absence of vagina, cervix and uterus, coexisting urinary tract anomalies in 1/3 of women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Trisomy 13

A

Patau Syndrome: midline defects, microcephaly, holoprosencephaly, umbilcial hernia, omphalocele, cutis aplasia, polydactyly, rocker bottom feet, cardiac/renal defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Trisomy 18

A

Edward Syndrome: clenched hands with overlapping fingers, cardiac anomalies (VSD, ASD, PDA)

Quad screen: all decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Trisomy 21

A

Endocardial cushion defects, flat facial profile, epicanthic folds

Quad screen: High hcg and inhibin A, low uE3 and AFP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Factor V Leiden

A

Testing is reliable during pregnancy and acute thrombosis; but not with anti-coagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prothrombin G20210A mutation

A

Testing is reliable during pregnancy, during acute thrombosis, and with anti-coagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Protein C Deficiency

A

Only reliable during pregnancy, test not reliable during acute thrombosis or with anticoagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Protein S Deficiency

A

Not reliable in pregnancy, during acute thrombosis or with anticoagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Antithrombin deficiency

A

Only reliable during pregnancy, test not reliable during acute thrombosis or with anticoagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Normal semen analysis

A

15 million spermatozoa/ml, 39 million spermatozoa per ejaculate, 32% progressive motility, 40% total motility, 4% normal morphology, 58% vitality and 1.5 mL ejaculate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Central precocious puberty

A

GnRH dependent, caused by early activation of HPO axis; diagnosis is made by measuring LH levels before/after GnRH stimulation (stimulated LH levels >5-8) is diagnostic, Tx: GnRH analog

21
Q

Peripheral precocious puberty

A

GnRH independent; caused by excess estrogen or androgen, exposure from gonadal, adnexal or external sources, LH levels are in pre-adolescent range and do not respond to stimulation with GnRH; US is indicated to look for ovarian cysts and tumors

22
Q

Lynch Syndrome

A

IHC testing for women with endometrial cancer who are younger than 60. Test endometrial tissue. If MLH1 protein absent then assess for MLH1 promoter methylation (if methylation is absent then next step is germline DNA testing) If methylation is present–> not LS

23
Q

Cowden Syndrome

A

Associated with PTEN overexpression, associated with breast cancer, thyroid cancer, endometrial cancer, colon cancer and benign mucocutaneous lesions

24
Q

Li-Fraumeni Syndrome

A

Associated with TP53 mutations, associated with high risk of soft tissue sarcomas, leukemia, adrenocortical cancer, breast cancer and brain cancer

25
Q

Puetz-Jeghers Syndrome

A

STK11 gene mutations; hamartomatous polyps throughout GI tract, mucocutaneous hyperpigmentation of the mouth, lips, eyes, nose and genitalia; increased risk of breast, ovarian, uterine, pancreatic, lungs, stomach,, colon and ovarian sex cord tumors

26
Q

Vulvar Cancer Staging: I

A

Stage I: confined to vulvar/perineum
IA: lesion 2cm or less and with stromal invasion of 1 mm or less
IB: lesion more than 2 cm or any size with stromal invasion of more than 1 mm

27
Q

Vulvar Cancer Staging: II

A

Tumor of any size with extension to adjacent perineal structures (distal third of urethra, distal third of vagina, anal involvement)

28
Q

Vulvar Cancer Staging: III

A

IIIA: 1 or 2 LN each less than 5 mm; one lump node met grater than or equal to 5mm
IIIB: 3 or more LN each less than 5mm or two ore more LN > or equal to 5mm
IIIC: positive inguinal lymph nodes

29
Q

Vulvar Cancer Staging: IV

A

IVA: extension to proximal 2/3 of urethra, proximal 2/3 of vagina, bladder mucosa or rectal mucosa
IVB: + pelvic LN

30
Q

Endometrial Cancer Staging: I

A

IA: limited to endometrium or less than half of myometrium
IB: one half or more of myometrium

31
Q

Endometrial Cancer Staging: II

A

Invades stromal connective tissue of cervix, NO endocervical glandular involvement

32
Q

Endometrial Cancer Staging: IIIA and IIIB

A

IIIA: involves serosa and/or adnexa
IIIB: vaginal or parametrial involvement

33
Q

Endometrial Cancer Staging: IIIC

A

Lymph node mets
IIIC1: involves pelvic lymph nodes, IIIC2: involves para-aortic lymph nodes (with or without positive pelvic lymph nodes)

34
Q

Cervical Cancer Staging: IA

A

IA1: stromal invasion 3mm or less
IA2: stromal invasion greater than 3mm and less than or equal to 5mm

35
Q

Cervical Cancer Staging: IB

A

IB1: invasive carcinoma > 5mm depth of stromal invasion and 2cm or less
IB2: >2cm and less than or equal to 4cm
IB3: >4cm

36
Q

Cervical Cancer Staging: II

A

IIA: Involves 2/3 of vagina
IIA1: less than or equal to 4cm
IIA2: >4cm
IIB: with parametrial involvement

37
Q

Cervical Cancer Staging: III

A

IIIA: involves lower 1/3 of vagina
IIIB: extension to pelvic wall
IIIC1: Pelvic LN
IIIC2: Para-aortic LN

38
Q

Cervical Cancer Staging: IV

A

IVA: spread to adjacent pelvic organs
IVB: spread to distant organs

39
Q

Ovarian Cancer Staging: I

A

IA: limited to one ovary or tube
IB: both ovaries or tubes
IC3: malignant cells in ascites or peritoneal washings

40
Q

Ovarian Cancer Staging: II

A

IIA: extension/implants on uterus
IIB: extension/implants on other pelvic tissues

41
Q

Ovarian Cancer Staging: III

A

IIIA1: + retroperitoneal lymph nodes
IIIA2: microscopic extrapelvic (above the pelvic brim) peritoneal involvement

42
Q

Ovarian Cancer Staging: IV

A

IVA: pleural effusion w/ positive cytology
IVB: liver or splenic mets, transmural involvement of intestine, inguinal LN and LN outside the abdominal cavity

43
Q

Relative contraindications to MTX

A

Adnexal mass >4cm in diameter, + fetal cardiac activity, bhcg of 6000-15000

44
Q

When to screen for bone density before age 65

A

history of a fragility fracture, body weight <127lbs, medical causes of bone loss, parental medical hx of hip fracture, current smoker, alcoholism, RA

45
Q

When to FRAX

A

In women <65. Those with FRAX 10-year risk of major osteoporotic fracture of 9.3%–> do DEXA

46
Q

Clinical factors of FRAX

A

age, sex, bmi, previous fragility fracture, parental hip fracture, current smoking status, steroid use, etoh intake >3 drinks, RA and other secondary causes of osteoporosis

47
Q

When to start treatment for osteoporosis?

A

When there is a 3% risk of hip fracture or a 20% risk of a major osteoporotic fracture

48
Q

Raloxifene

A

Better suited for younger postmenopausal woman with osteoporosis who is at low risk of hip fracture and stroke by virtue of her age and who is often concerned about breast cancer and osteoporosis

49
Q

Diagnosing gestational diabetes

A

1-hr 50g glucose load, >130 is abnormal. Then move to 3-hr 1000g glucose load: normal is fasting <95, 1-hour <180, 2-hour <155 and 3-hour <140.

CREOGS (1 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions